Angiodynamics (ANGO) Return on Capital Employed (2011 - 2026)
Angiodynamics (ANGO) reported Return on Capital Employed of 17.84% for Q1 2026, up 525.0% on a YoY basis from 2.85% in Q1 2025, and down 7.28% quarter-over-quarter from 16.63% in Q4 2025.
Angiodynamics (ANGO) Return on Capital Employed (2011 - 2026) Analysis & Trends
Angiodynamics has reported Return on Capital Employed for 16 years, with the latest figure at 17.84% in Q1 2026.
- For the quarter ending Q1 2026, Return on Capital Employed rose 525.0% year-over-year to 17.84%; the trailing twelve-month figure through Feb 2026 stood at 17.84% (up 525.0% YoY), and the FY2025 full-year result was 17.94%, up 3968.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 17.84%, down from 16.63% in the prior quarter.
- The five-year high for Return on Capital Employed was 0.63% in Q3 2023, with the low at 116.93% in Q4 2024.
- Historically, Return on Capital Employed has averaged 30.1% across 5 years, with a median of 16.63% in 2025.
- Annual changes were most pronounced in 2024 — Return on Capital Employed slumped 11506 bps — and 2025, when it surged 10030 bps.
- Angiodynamics' Return on Capital Employed stood at 6.84% in 2022, then surged by 73 bps to 1.88% in 2023, then tumbled by 6134 bps to 116.93% in 2024, then soared by 86 bps to 16.63% in 2025, then retreated by 7 bps to 17.84% in 2026.
- The last three Return on Capital Employed figures came in at 17.84% (Q1 2026), 16.63% (Q4 2025), and 18.33% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 17.54% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 5.02% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | - |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 25.95% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 18.63% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 19.44% |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 4.68% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 12.74% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 13.02% |
| 10 | Angiodynamics | 505.81 Mn | 468.00 Mn | 41.48 Mn | -17.84% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -17.84% |
| Nov 30, 2025 | -16.63% |
| Aug 31, 2025 | -18.33% |
| May 31, 2025 | -19.34% |
| Feb 28, 2025 | -23.09% |
| Nov 30, 2024 | -116.93% |
| Aug 31, 2024 | -105.07% |
| May 31, 2024 | -83.63% |
| Feb 29, 2024 | -60.92% |
| Nov 30, 2023 | -1.88% |
| Aug 31, 2023 | -0.63% |
| May 31, 2023 | -11.28% |
| Feb 28, 2023 | -7.64% |
| Nov 30, 2022 | -6.84% |
| Aug 31, 2022 | -6.89% |
| May 31, 2022 | -6.01% |
| Feb 28, 2022 | -8.74% |
| Nov 30, 2021 | -8.41% |
| Aug 31, 2021 | -7.55% |
| May 31, 2021 | -6.86% |